Sylvain Lehoux, PhD, has extensive experience in biochemistry and glycobiology, beginning as a PhD candidate at the University of Lille 1 Sciences and Technology, where research focused on the transcriptional regulation of the ST6Gal2 gene expressed in the human cerebral cortex. Following this, Sylvain served as a Post-Doctoral Fellow at Emory University School of Medicine, developing advanced molecular and proteomic assays. Subsequent roles included Senior Research Scientist at NovAb, creating innovative antibodies based on the sea lamprey immune system, and Director of the Glycomics Core at Beth Israel Deaconess Medical Center, managing over 50 projects annually and providing expert guidance in glycobiology. Sylvain currently holds the position of Principal Scientist at Lectenz Bio, focusing on developing new research tools in glycobiology. Educational credentials include a Master's degree and a PhD in Biochemistry and Molecular Biology from the University of Sciences and Technologies of Lille.
This person is not in the org chart
This person is not in any teams
This person is not in any offices